Surmodics reported $24.85M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11257M 638M
Align Technology ALGN:US $ 969.55M 3.67M
Anika Therapeutics ANIK:US $ 39.66M 2.96M
Arrowhead Research ARWR:US $ 32.41M 119.39M
Baxter International BAX:US $ 3746M 39M
Bioscrip BIOS:US $ 980.82M 65.04M
Boston Scientific BSX:US $ 3244M 218M
Cryolife CRY:US $ 80.34M 3.13M
Edap Tms EDAP:US $ 14.38M 0.41M
Edwards Lifesciences EW:US $ 1373.9M 32.7M
Haemonetics HAE:US $ 261.46M 3.54M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Johnson & Johnson JNJ:US $ 24020M 594M
Merit Medical Systems MMSI:US $ 294.98M 19.56M
Mesa Laboratories MLAB:US $ 50.45M 8.43M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Stryker SYK:US $ 4493M 218M
Surmodics SRDX:US $ 24.85M 1.25M
Trinity Biotech TRIB:US $ 18.78M 0.75M